{"version":"1.0","type":"link","title":"Synergistic Anticancer Effects of COL6A1 Downregulation and the PD1 Inhibitor Pembrolizumab in Bladder Cancer.","author_name":"Yuan F 외","author_url":"https://prs-insight.online/author/Yuan%20F","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169946","thumbnail_width":1200,"thumbnail_height":630}